查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1732185

全球羊膜穿刺针市场规模（按类型、程序、最终用户、地区、范围和预测）

Global Amniocentesis Needle Market Size By Type, By Procedure, By End-User, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

羊膜穿刺针市场规模及预测

2024 年羊膜穿刺针市场规模为 1.8143 亿美元，预计到 2032 年将达到 2.2015 亿美元，2026 年至 2032 年的复合年增长率为 2.7%。

推动全球羊膜穿刺针市场的因素

羊膜穿刺针市场的市场驱动因素可能受到多种因素的影响。这些包括：

随着产妇年龄的增长，羊膜穿刺等产前诊断程序变得越来越受欢迎，因为女性出于各种原因不愿生育。这些程序可以评估胎儿的健康状况、基因异常和其他疾病。

遗传性疾病的流行羊膜穿刺术等产前诊断技术对于早期发现和治疗唐氏症和脊柱裂等遗传性疾病和染色体异常是必要的。

技术发展：羊膜穿刺针技术已经改进，针头变得更小、更精确，成像方式更好，出现问题的风险也更低。这些发展使得测试更加安全、更准确，加速了市场发展。

提高意识：产前筛检和诊断在预防和治疗胎儿异常和出生缺陷方面的作用越来越受到准父母和医疗专业人士的认可，从而支持了市场的成长。

政府措施和医疗保健政策：透过降低产前检测成本并提高其可近性，特别是对于高风险妊娠，政府倡议、医疗保健政策和报销计划可以显着促进市场扩张。

医疗保健支出不断增加：医疗保健支出不断增加，尤其是在新兴国家，使得更多人能够获得先进的产前护理和羊膜穿刺术等诊断程序。

文明病的流行：对羊膜穿刺术等产前诊断技术的需求是由于与影响未出生婴儿健康的生活方式和环境因素相关的疾病的流行率不断上升，例如孕妇肥胖、糖尿病和接触污染物。

怀孕率上升：由于人口成长、生育治疗的改善和社会标准的变化等因素导致整体怀孕率上升，羊膜穿刺针市场正在成长。

积极的法规环境：监管核准和指南透过增强客户信心和促进产品采用来确保羊膜穿刺术和相关技术的安全性和有效性，从而推动市场成长。

限制全球羊膜穿刺针市场的因素

有几个因素可能会对羊膜穿刺针市场造成限製或挑战。这些包括：

监管障碍：管理医疗设备和程序的严格法规可能给生产商和医疗保健从业者带来挑战，导致核准延迟和合规成本高昂。

併发症风险：儘管羊膜穿刺术是一项常规手术，但流产是其相关风险之一。如果对相关风险的担忧导致孕妇不愿意接受治疗，那么市场潜力可能会受到限制。

替代筛检技术：非侵入性产前检测（NIPT）和其他筛检技术的发展作为传统羊膜穿刺术的替代方案，可能会减少对羊膜穿刺针的需求。

伦理与社会考量：产前检测的伦理问题以及检测出特定基因异常可能造成的后果可能会影响患者和医疗保健专业人员的决定。这可能会影响羊膜穿刺术的需求。

成本限制：羊膜穿刺术治疗费用昂贵，特别是对于保险不足的人来说。成本可能会限制这些手术的可近性，特别是在医疗保健系统不发达或社会经济地位较低的地区。

技术挑战：羊膜穿刺术是一种成熟的手术，但需要不断改进针头设计和成像技术，以提高安全性和准确性。然而，高昂的研发成本和技术限制可能会阻碍这种进步。

患者的焦虑和恐惧：人们可能会因为害怕手术的疼痛和不适或担心手术可能产生的结果而犹豫是否接受羊膜穿刺术，这可能会影响市场需求。

知识和教育程度低：羊膜穿刺术未充分利用的原因是患者和医疗保健专业人员对该手术的益处、风险和适应症缺乏了解。

目录

第一章全球羊膜穿刺针市场介绍

  • 市场概览
  • 研究范围
  • 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

  • 资料探勘
  • 验证
  • 第一手资料
  • 资料来源列表

第四章 全球羊膜穿刺针市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 限制因素
    • 机会
  • 波特五力模型
  • 价值链分析

第五章 全球羊膜穿刺针市场（依类型）

  • 概述
  • 100mm至150mm针头
  • 大于150mm的针头
  • 小于100mm的针头

6. 全球羊膜穿刺针市场（依程序）

  • 概述
  • 羊膜穿刺术
  • 羊膜腔灌注法
  • 羊水减少法
  • 脐带穿刺术
  • 胎儿输血程序

7. 全球羊膜穿刺针市场（依最终用户）

  • 概述
  • 医院
  • 诊断中心
  • 诊所
  • 其他的

8. 全球羊膜穿刺针市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 世界其他地区
    • 拉丁美洲
    • 中东和非洲

第九章全球羊膜穿刺针市场的竞争格局

  • 概述
  • 各公司市场排名
  • 主要发展策略

第十章 公司简介

  • Becton, Dickinson and Company
  • Cook Medical
  • RI.MOS. Srl
  • Smiths Medical
  • Laboratoire Ccd
  • Biopsybell
  • Integra Lifesciences
  • Medtronic Plc
  • Coopersurgical
  • Medline

第十一章 附录

  • 相关调查
简介目录
Product Code: 32507

Amniocentesis Needle Market Size And Forecast

Amniocentesis Needle Market size was valued at USD 181.43 Million in 2024 and is projected to reach USD 220.15 Million by 2032, growing at a CAGR of 2.7% from 2026 to 2032.

Global Amniocentesis Needle Market Drivers

The market drivers for the Amniocentesis Needle Market can be influenced by various factors. These may include:

Growing Maternal Age: Prenatal diagnostic treatments like amniocentesis, which evaluate foetal health, genetic abnormalities, and other disorders, are becoming more and more popular as women put off having children for a variety of reasons.

Prevalence of Genetic Disorders: Prenatal diagnostic techniques like amniocentesis are necessary for the early detection and treatment of genetic disorders and chromosomal abnormalities, such as Down syndrome, spina bifida, and others, due to their increasing incidence.

Technological Developments: Amniocentesis needle technology has advanced to produce thinner, more accurate needles, better imaging methods, and a lower risk of problems. These developments make the process safer and more accurate, which in turn accelerates market growth.

Expanding Awareness: Prenatal screening and diagnosis's role in preventing or treating foetal anomalies and birth defects is being increasingly recognised by pregnant parents and medical professionals, which supports the market's growth.

Government Initiatives and Healthcare Policies: By lowering the cost and increasing the accessibility of prenatal testing methods, particularly for high-risk pregnancies, government initiatives, healthcare policies, and reimbursement programmes can substantially propel market expansion.

Growing Healthcare Expenditure: More people can now obtain sophisticated prenatal care and diagnostic procedures, such as amniocentesis, thanks to rising healthcare spending, especially in emerging nations.

Prevalence of Lifestyle disorders: The need for prenatal diagnostic techniques like amniocentesis is fueled by the rising prevalence of disorders linked to a lifestyle and environmental factors that impact foetal health, such as mother obesity, diabetes, and exposure to pollutants.

Increase in Pregnancy Rates: The market for amniocentesis needles is growing as a result of the general increase in pregnancy rates, which is being driven by factors like population growth, improvements in fertility treatments, and shifting societal standards.

Positive Regulatory Environment: By boosting customer trust and easing product uptake, regulatory approvals and guidelines guaranteeing the safety and effectiveness of amniocentesis procedures and related technologies promote market growth.

Global Amniocentesis Needle Market Restraints

Several factors can act as restraints or challenges for the Amniocentesis Needle Market. These may include:

Regulatory Obstacles: Tight rules governing medical devices and practices can cause difficulties for producers and healthcare practitioners, resulting in approval delays or higher compliance costs.

Risk of Complications: Miscarriage is one of the hazards associated with amniocentesis, despite it being a regular treatment. The market potential may be limited if expecting mothers are discouraged from undergoing the treatment due to concerns about the associated hazards.

Alternative Screening Technologies: The necessity for amniocentesis needles may be decreased by the development of non-invasive prenatal testing (NIPT) and other screening technologies as alternatives to conventional amniocentesis.

Ethical and Social Considerations: Patients' and healthcare professionals' decisions may be influenced by ethical concerns about prenatal testing and the possible ramifications of detecting specific genetic abnormalities. This could have an effect on the demand for amniocentesis operations.

Cost Restrictions: Amniocentesis treatments can be costly, particularly for those without sufficient insurance. Access to these operations may be restricted due to cost, especially in areas with less developed healthcare systems or lower socioeconomic status.

Technological Challenges: Amniocentesis is a well-established procedure, but to increase safety and accuracy, continuous improvements in needle design and imaging technology would be needed. High research and development expenses or technological constraints, however, may prevent the creation of such advances.

Patient Anxiety and Fear: Some people may be discouraged from having amniocentesis due to fear of the procedure's pain or discomfort or worry about the procedure's possible outcomes, which could impact market demand.

Low Knowledge and Education: Underutilization of amniocentesis may be caused by low knowledge among patients and healthcare professionals on the advantages, dangers, and indications of the treatment, especially in areas with limited access to prenatal care or educational resources.

Global Amniocentesis Needle Market: Segmentation Analysis

The Global Amniocentesis Needle Market is Segmented on the basis of Type, Procedure, End-User, and Geography.

Amniocentesis Needle Market, By Type

100-150 mm Needles

  • Larger Than 150 mm Needles
  • Smaller Than 100 mm Needles

Based on Type, the market is bifurcated into 100-150 mm Needles, Larger than 150 mm Needles, and Smaller Than 100 mm Needles. The 100-150 mm needles segment is expected to hold the largest market share. The factors can be attributed to the suitability of use for most patients and the widespread use of these needles on account of their optimal length.

Amniocentesis Needle Market, By Procedure

  • Amniocentesis Procedures
  • Amnioinfusion Procedures
  • Amnioreduction Procedures
  • Cordocentesis Procedures
  • Fetal Blood Transfusion Procedures

Based on the Procedure, the market is bifurcated into Amniocentesis Procedures, Amnioinfusion Procedures, Amnioreduction Procedures, Cordocentesis Procedures, and Fetal Blood Transfusion Procedures. Amniocentesis Procedures are predicted to hold the most significant CAGR in the forecasted period due to the extensive use of this procedure to diagnose the abnormalities in the developing fetus and the high reliability of the amniocentesis technique.

Amniocentesis Needle Market, By End-User

  • Hospitals
  • Diagnostic Centers
  • Clinics
  • Others

Based on End-User, the market is bifurcated into Hospitals, Diagnostic Centers, Clinics, and Others. Hospitals are anticipated to hold the largest market share. The factors can be credited to the rising number of hospitals and better accessibility & availability of test results in hospitals.

Amniocentesis Needle Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

Based on regional analysis, the Global Amniocentesis Needle Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to the growing healthcare expenditure and increasing government initiatives in this region.

Key Players

  • The major players in the Amniocentesis Needle Market are:
  • Becton Dickinson and Company
  • Cook Medical
  • MOS. Srl
  • Smiths Medical
  • Laboratoire Ccd
  • Biopsybell
  • Integra Lifesciences
  • Rocket Medical plc
  • Teleflex Incorporated
  • Terumo Corporation

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL AMNIOCENTESIS NEEDLE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL AMNIOCENTESIS NEEDLE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY TYPE

  • 5.1 Overview
  • 5.2100-150 mm Needles
  • 5.3 Larger Than150 mm Needles
  • 5.4 Smaller Than100 mm Needles

6 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY PROCEDURE

  • 6.1 Overview
  • 6.2 Amniocentesis Procedures
  • 6.3 Amnioinfusion Procedures
  • 6.4 Amnioreduction Procedures
  • 6.5 Cordocentesis Procedures
  • 6.6 Fetal Blood Transfusion Procedures

7 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY END-USER

  • 7.1 Overview
  • 7.2 Hospitals
  • 7.3 Diagnostic Centers
  • 7.4 Clinics
  • 7.5 Others

8 GLOBAL AMNIOCENTESIS NEEDLE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East & Africa

9 GLOBAL AMNIOCENTESIS NEEDLE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Becton, Dickinson and Company
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Cook Medical
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 RI.MOS. Srl
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Smiths Medical
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Laboratoire Ccd
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 Biopsybell
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Integra Lifesciences
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Medtronic Plc
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Coopersurgical
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Medline
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 Appendix

  • 11.1 Related Research